ROYAL BANK OF CANADA - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 24 filers reported holding TENAX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$0290.0%0.00%
Q3 2017$029
-91.9%
0.00%
Q2 2017$0359
-21.8%
0.00%
Q1 2017$0
-100.0%
4590.0%0.00%
Q4 2016$1,0000.0%4590.0%0.00%
Q3 2016$1,0000.0%4590.0%0.00%
Q2 2016$1,0000.0%459
-3.6%
0.00%
Q1 2016$1,000
-50.0%
4760.0%0.00%
Q4 2015$2,0000.0%476
-28.0%
0.00%
Q3 2015$2,000
-33.3%
6610.0%0.00%
Q2 2015$3,000
+200.0%
661
+36.9%
0.00%
Q1 2015$1,000
-50.0%
483
+5.2%
0.00%
Q4 2014$2,000
-33.3%
459
-43.3%
0.00%
Q3 2014$3,0008090.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
FAS Wealth Partners, Inc. 1,291,932$466,0000.13%
Virtu Financial LLC 103,425$37,0000.00%
Verition Fund Management LLC 32,140$12,0000.00%
Baker Brothers Advisors 348,374$126,0000.00%
Cardinal Capital Management 10,000$3,0000.00%
TWO SIGMA SECURITIES, LLC 21,500$8,0000.00%
BANK OF AMERICA CORP /DE/ 1,079$00.00%
WELLS FARGO & COMPANY/MN 1$00.00%
NORTHERN TRUST CORP 51,187$18,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 87,632$31,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders